AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)–JNK (c-Jun N-terminal kinase)–ATF3 (activating transcription factor 3) pathway
AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)–JNK (c-Jun N-terminal kinase)–ATF3 (activating transcription factor 3) pathway
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started